GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.
GlycoEra has raised €157M across 2 funding rounds from 12 investors, most recently a Series B round in May 2025. Based in Schlieren, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2025-05-27 | Series B | €114M | 5AM Ventures,Agent Capital,Bristol Myers Squibb,Catalio Capital Management,LifeArc Ventures,MP Healthcare Venture Management+5 more | View deal → |
| 2021-11-12 | Series A | €43M | 5AM Ventures,Roche Venture Fund,Sofinnova Partners | View deal → |
